 0001144204-11-042918.txt : 20110729 0001144204-11-042918.hdr.sgml : 20110729 20110729170046 accession number:		0001144204-11-042918 conformed submission type:	sc 13d public document count:		1 filed as of date:		20110729 date as of change:		20110729 filed by:		 	company data:	 		company conformed name:			moshiri mahmood 		central index key:			0001518740 	filing values: 		form type:		sc 13d 	mail address:	 		street 1:		88 toporowski avenue 		city:			richmond hill 		state:			a6 		zip:			l4s2v6 subject company:	 	company data:	 		company conformed name:			panacea global, inc. 		central index key:			0001024048 		standard industrial classification:	real estate agents & managers (for others) [6531] 		irs number:				330680443 		state of incorporation:			nv 		fiscal year end:			1231 	filing values: 		form type:		sc 13d 		sec act:		1934 act 		sec file number:	005-79751 		film number:		11998094 	business address:	 		street 1:		88 toporowski avenue 		city:			richmond hill 		state:			a6 		zip:			l4s 2v6 		business phone:		714-418-1414 	mail address:	 		street 1:		88 toporowski avenue 		city:			richmond hill 		state:			a6 		zip:			l4s 2v6 	former company:	 		former conformed name:	moneylogix group inc. 		date of name change:	20080411 	former company:	 		former conformed name:	homelife inc 		date of name change:	19980828 sc 13d 1 v230286_sc13d.htm unassociated document &#160; securities and exchange commission washington, d.c.&#160;20549 &#160; schedule 13d &#160; under the securities exchange act of 1934 &#160; panacea global, inc. (name of issuer) &#160; common stock, $0.001 par value per share (title of class of securities) 007373103 &#160;(cusip number) panacea global, inc. 88 toporowski ave., richmond hill ontario, canada l4s2v6 &#160;(name, address and telephone number of person authorized to receive notices and communications) &#160; with copies to: anslow &amp; jaclin, llp 195 route 9 south, suite 204 manalapan, nj&#160;07726 (732) 409-1212 &#160; june 30, 2010 &#160;(date of event which requires filing of this statement) &#160; if the filing person has previously filed a statement on schedule 13g to report the acquisition which is the subject of this schedule 13d, and is filing this schedule because of rule 13d-1(e), (f) or (g), check the following box o . &#160; &#160; &#160; &#160; &#160; &#160; schedule 13d &#160; (1) names of reporting persons. s.s. or i.r.s. identification nos. of above persons (entities only): &#160; mahmood moshiri (2) check the appropriate box if a member of a group (see instructions) &#160; (a) o &#160; &#160; (b) o &#160; (3) sec use only (4) source of funds (see instructions) &#160; oo&#160;&#160;&#160;&#160; (5) check if disclosure of legal proceedings is required pursuant to items 2(d) or 2(e) o (6) citizenship or place of organization &#160; canada number of shares beneficially owned by each reporting person with &#160; (7)&#160;&#160;&#160;sole voting power &#160; 14,800,000 &#160; (8)&#160;&#160;&#160;shared voting power &#160; 0 &#160; (9)&#160;&#160;&#160;sole dispositive power &#160; 14,800,000 &#160; (10)&#160;shared dispositive power &#160; 0 &#160; (11) &#160;aggregate amount beneficially owned by each reporting person (12) check if the aggregate amount in row (11) excludes certain shares o (13) percent of class represented by amount in row (11) &#160; 16.7% (14) type of reporting person &#160; in&#160; &#160; &#160; &#160; &#160; item 1. security and issuer. &#160; this statement on schedule 13d (this &#8220;statement&#8221;) relates to the common stock, par value $0.001 (&#8220;common stock&#8221;), of panacea global, inc., a nevada corporation (the &#8220;company&#8221;).&#160;&#160;the principal executive offices of the company are located at 88 toporowski ave, richmond hill, ontario, canada, l4s2v6 item 2. identity and background. &#160; (a)&#160;&#160; this statement is filed by mahmood moshiri (the &#8220;reporting person&#8221;). (b)&#160;&#160; the reporting person&#8217;s business address is 88 toporowski ave, richmond hill, ontario, canada, l4s2v6. (c)&#160;&#160; the reporting person is the president, chief executive officer and chief medical officer of the company. (d)&#160;&#160; during the past five years, the reporting person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e)&#160;&#160; during the past five years, the reporting person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding, was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f)&#160;&#160; the reporting person is a citizen of canada. item 3. source and amount of funds or other consideration. &#160; on june 30, 2010 (the &#8220;closing date&#8221;) the company entered into a share exchange agreement (the &#8220;exchange agreement&#8221;), by and among the company, panacea global, inc., a delaware corporation (&#8220;panacea&#8221;), and the shareholders of panacea (the &#8220;panacea shareholders&#8221;).&#160;&#160; on the closing date, pursuant to the terms of the exchange agreement, the company acquired 100% of the outstanding shares of panacea (the &#8220;panacea shares&#8221;) from the panacea shareholders, and the panacea shareholders transferred and contributed 100% of the panacea shares to the company. in exchange, the company issued to the panacea shareholders, their designees or assigns, 74,800,000 shares representing 83.7% of the outstanding shares of the company&#8217;s common stock issued and outstanding after the closing (the &#8220;share exchange&#8221;). as a result of the share exchange, the reporting person acquired 14,800,000 shares of the company&#8217;s common stock. the foregoing description of the terms of the exchange agreement is qualified in its entirety by reference to the provisions of the exchange agreement filed as exhibit 2.1 to this statement, which is incorporated by reference herein. item 4. purpose of transaction. &#160; the purpose of the share exchange was for the company to obtain 100% ownership of panacea and for the reporting person to obtain an interest in the company. the reporting person intends to review his investments in the company on a continuing basis and may, at any time, consistent with the obligations of the reporting person under the federal securities laws, determine to increase or decrease his respective ownership of shares of common stock through transactions in open market ordinary brokerage transactions, in privately negotiated transactions, by gift or other disposition.&#160;&#160;the review of his investments in the company by the reporting person will depend on various factors, including the company&#8217;s business prospects, other developments concerning the company, alternative investment opportunities, general economic conditions, money and stock market conditions, personal circumstances, and any other facts and circumstances which may become known to the reporting person regarding his investments in the company.&#160;&#160;at the time of filing this statement, the reporting person has no plans to acquire additional shares of common stock of the company in open market ordinary brokerage transactions or in privately negotiated transactions but may engage in such transactions in the future. as of the date of this statement, other than the reporting person&#8217;s activities as president and chief executive officer of the company and as a member of its board of directors and except as described in item 6 of this statement, the reporting person does not have any plans or proposals which relate to or would result in: (a) the acquisition by any person of additional securities of the company, or the disposition of securities of the company; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation , involving the company or any of its subsidiaries; (c) a sale or transfer of a material amount of assets of the company or of any of its subsidiaries; (d) any change in the present board of directors or management of the company, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) any material change in the present capitalization or dividend policy of the company; (f) any other material change in the company&#8217;s business or corporate structure; (g) changes in the company&#8217;s charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the issuer by any other person; (h) causing a class of securities of the company to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) a class of equity securities of the company becoming eligible for termination of registration pursuant to section 12(g)(4) of the securities act of 1933, as amended; or (j) any similar action to those enumerated above. &#160; &#160; &#160; &#160; item 5. interest in securities of the issuer. &#160; (a)&#160;&#160; the aggregate number of shares of common stock that are beneficially owned by the reporting person is 14,800,000, which represents 16.7% of the outstanding shares of common stock. (b)&#160;&#160; the reporting person has the sole power to control the vote of, and dispose of, all of such beneficially owned shares of common stock. (c)&#160;&#160; other than the acquisition of the shares of common stock as reported in this schedule 13d, the reporting person has not effected any transactions in the common stock of the company in the past sixty (60) days. (d)&#160;&#160; not applicable. (e)&#160;&#160; not applicable. item 6. contracts, arrangements, understandings or relationships with respect to securities of the issuer. &#160; none. item 7. material to be filed as exhibits. &#160; exhibit 2.1 &#160; share exchange agreement, dated june 30 2010, by and among the company, panacea global, inc., a delaware corporation (&#8220;panacea&#8221;), and the shareholders of panacea [incorporated by reference to exhibit 2.1 of&#160;&#160;the company&#8217;s current report on form 8-k filed with the securities and exchange commission on july 8, 2010] signature &#160; after reasonable inquiry and to the best of my knowledge and belief, i certify that the information set forth in this statement is true, complete and correct. &#160; &#160; date: july 29, 2011&#160; &#160; /s/ mahmood moshiri&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; mahmood moshiri &#160; &#160; &#160; &#160; &#160; 